Citations

Showing 10 of 108081 citations.

Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer
Goss, Paul E. , Ingle, J. N., Martino, Silvana, Robert, Nicholas J. , Muss, H. B., Piccart, Martine , Castiglione, Monica, Shepherd, L. E., Pater, Joseph L. , Tu, Dongsheng

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 847-847

10.1200/jco.2004.22.90140.847 Get It

Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633
Strauss, Gary M., Maddaus, Michael A. , Johnstone, David W., Watson, Dorothy, Sugarbaker, David J., Schilsky, Richard L. , Green, M. R., Herndon, Justine , Johnson, Eric A.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 7019-7019

10.1200/jco.2004.22.90140.7019 Get It

Turning free speech into commercial speech: Philip Morris' use of journalists to discredit the EPA report on secondhand smoke
Hurt, R. Douglas , Muggli, Monique E , Becker, Lee B.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6151-6151

10.1200/jco.2004.22.90140.6151 Get It

Focal HER2/neu amplified clones partially account for discordance between immunohistochemistry and fluorescence in-situ hybridization results: data from NCCTG N9831 Intergroup Adjuvant Trial
Miller, Dylan V. , Jenkins, Robert B. , Lingle, Wilma L., Davidson, Nancy E. , Martino, Silvana, Dakhil, Shaker R. , Perez, Edith A. , Kaufman, Peter A.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 568-568

10.1200/jco.2004.22.90140.568 Get It

HER2 testing by local, central, and reference laboratories in the NCCTG N9831 Intergroup Adjuvant Trial
Perez, Edith A. , Davidson, Nancy E. , Martino, Silvana, Lingle, Wilma L., Flynn, Patrick J. , Visscher, Daniel W., Jenkins, Robert B. , Suman, Vera J. , Kaufman, Peter A. , Ingle, James N.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 567-567

10.1200/jco.2004.22.90140.567 Get It

N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study
Goldberg, Richard M. , Morton, Roscoe F., Fuchs, Charles S. , Ramanathan, R. K., Findlay, B., Pitot, H., Sargent, Daniel J. , Williamson, Stephen K. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3621-3621

10.1200/jco.2004.22.90140.3621 Get It

SWOG 99–16: Randomized phase III trial of docetaxel (D)/estramustine (E) versus mitoxantrone(M)/prednisone(p) in men with androgen-independent prostate cancer (AIPCA)
Petrylak, D. P., Tangen, C., Lara, P. N. , Jones, J., Talpin, M. E., Burch, P., Greene, G., Crawford, E. D., Hussain, Maha , Burch, P. A., Small, Eric J.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3-3

10.1200/jco.2004.22.90140.3 Get It

Intervention radiology for venous thrombosis: early thrombus removal using invasive methods
Casanegra, Ana I. , McBane, Robert D. , Bjarnason, Haraldur , McBane, Robert , Casanegra, Ana I , Bjarnason, Haraldur

Mayo Clinic

British Journal of Haematology | April 5, 2017 | Volume: 177 | Issue: 2 | Pages: 173-184

10.1111/bjh.14581 | PMID 28369771 Get It

SummaryThe post thrombotic syndrome is one of the most dreaded complications of proximal deep vein thrombosis. This syndrome leads to pain and suffering with leg swelling, recalcitrant ulceration and venous claudication which greatly impairs mobility and quality of life. The prevalence can be high in patients with iliofemoral venous involvement particularly in the setting of a proximal venous stenosis, such as occurs in May Thurner syndrome. Anticoagulation alone does not reduce the likelihood of this outcome. Compression therapy may be effective but garment discomfort limits its implementation. Pharmacomechanical thrombectomy, which combines catheter‐directed thrombolysis with mechanical thrombus dissolution, provides an attractive treatment strategy for such patients. The rationale and delivery of pharmacomechanical thrombectomy, including patient selection and adjunctive antithrombotic therapy, will be reviewed in addition to tips and tricks for managing difficult patient scenarios.
A pooled analysis of demographic characteristics and clinical outcomes of phase I oncology clinical trials, the Mayo Clinic experience
Atherton, Pamela J. , Jasperson, Britta, Sloan, Jeffrey A., Mandrekar, Sumithra J. , Smith, Denise J., Erlichman, Charles , Adjei, Alex A.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 9724-9724

10.1200/jco.2004.22.90140.9724 Get It

KS1 (KRAB suppressor of transformation 1) and BMP3b (bone morphogenetic protein 3b) gene promoter hypermethylation is a common epigenetic event in breast cancer
Molina, Julian R. , Alzein, N. J., Lingle, Wilma L., Fernandez-Zampico, M., Hartmann, Lynn C. , Urrutia, Raúl

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 9608-9608

10.1200/jco.2004.22.90140.9608 Get It